Published in Circ Res on October 01, 2004
The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev (2011) 1.89
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol (2007) 1.71
Role of A-type lamins in signaling, transcription, and chromatin organization. J Cell Biol (2009) 1.68
Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun (2012) 1.66
Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells. Atherosclerosis (2010) 1.62
Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone (2008) 1.59
Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol (2005) 1.59
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55
Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem (2009) 1.33
Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals. J Cell Sci (2011) 1.33
Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. Am J Pathol (2007) 1.31
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
Partitioning the heart: mechanisms of cardiac septation and valve development. Development (2012) 1.13
Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. Stem Cells Dev (2012) 1.08
Progression and disruption of advanced atherosclerotic plaques in murine models. Curr Drug Targets (2008) 1.07
Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol (2014) 1.04
A review of metabolic staging in severely injured patients. Scand J Trauma Resusc Emerg Med (2010) 1.01
Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation. Biomed Res Int (2012) 0.99
Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury. J Vasc Res (2012) 0.99
Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi. Pflugers Arch (2009) 0.97
Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood. Stem Cell Rev (2009) 0.96
Mesenchymal stem cell mechanobiology and emerging experimental platforms. J R Soc Interface (2013) 0.96
Spheroid Culture of Mesenchymal Stem Cells. Stem Cells Int (2015) 0.96
Defining vascular stem cells. Stem Cells Dev (2013) 0.94
Renal capsule as a stem cell niche. Am J Physiol Renal Physiol (2010) 0.93
Pericytes: a universal adult tissue stem cell? Cytometry A (2011) 0.90
Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol (2007) 0.89
Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease - Implications for Clinical Applications and Donor Recruitment. Transfus Med Hemother (2008) 0.88
Transcriptional regulation of SM22alpha by Wnt3a: convergence with TGFbeta(1)/Smad signaling at a novel regulatory element. J Mol Cell Cardiol (2009) 0.87
Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section. Am J Pathol (2006) 0.87
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells. Retrovirology (2011) 0.85
Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor. Stem Cells Dev (2013) 0.85
Effects of BMSCs interactions with adventitial fibroblasts in transdifferentiation and ultrastructure processes. Int J Clin Exp Pathol (2014) 0.81
Origin and differentiation of vascular smooth muscle cells. J Physiol (2015) 0.81
Transcriptional profiling reveals crosstalk between mesenchymal stem cells and endothelial cells promoting prevascularization by reciprocal mechanisms. Stem Cells Dev (2014) 0.77
Rapidly self-renewing human multipotent marrow stromal cells (hMSC) express sialyl Lewis X and actively adhere to arterial endothelium in a chick embryo model system. PLoS One (2014) 0.76
Directing three-dimensional multicellular morphogenesis by self-organization of vascular mesenchymal cells in hyaluronic acid hydrogels. J Biol Eng (2017) 0.75
Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation. Stem Cells (2016) 0.75
TGF-β1/Smad signaling, MMP-14, and MSC markers in arterial injury: discovery of the molecular basis of restenosis. Int J Clin Exp Pathol (2014) 0.75
Heartburn in Staff of Golestan Medical University, Northeast of Iran. Gastroenterology Res (2009) 0.75
BMSCs Interactions with Adventitial Fibroblasts Display Smooth Muscle Cell Lineage Potential in Differentiation and Migration That Contributes to Neointimal Formation. Stem Cells Int (2016) 0.75
5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials. J Clin Med Res (2009) 0.75
Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development. PLoS One (2017) 0.75
Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol (2004) 4.02
Vascular calcification: pathobiology of a multifaceted disease. Circulation (2008) 3.64
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int (2010) 2.61
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation (2008) 2.44
Regulatory mechanisms in vascular calcification. Nat Rev Cardiol (2010) 2.22
Multilineage potential of cells from the artery wall. Circulation (2003) 2.17
Monocyte/macrophage regulation of vascular calcification in vitro. Circulation (2002) 1.67
Pitting phosphate transport inhibitors against vascular calcification. Circ Res (2006) 1.59
Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol (2003) 1.56
Pattern formation by vascular mesenchymal cells. Proc Natl Acad Sci U S A (2004) 1.54
Monocyte recruitment to endothelial cells in response to oscillatory shear stress. FASEB J (2003) 1.41
Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler Thromb Vasc Biol (2011) 1.34
Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol (2003) 1.29
8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem (2002) 1.26
High-density lipoprotein regulates calcification of vascular cells. Circ Res (2002) 1.22
Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol (2014) 1.21
Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol (2007) 1.21
Mechanical stress analysis of a rigid inclusion in distensible material: a model of atherosclerotic calcification and plaque vulnerability. Am J Physiol Heart Circ Physiol (2009) 1.18
Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem Biophys Res Commun (2008) 1.15
Endothelial cell dynamics under pulsating flows: significance of high versus low shear stress slew rates (d(tau)/dt). Ann Biomed Eng (2002) 1.10
Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss. Clin Immunol (2009) 1.09
Left-right symmetry breaking in tissue morphogenesis via cytoskeletal mechanics. Circ Res (2012) 1.02
Adverse effects of hyperlipidemia on bone regeneration and strength. J Bone Miner Res (2012) 1.01
Novel mechanisms in accelerated vascular calcification in renal disease patients. Curr Opin Nephrol Hypertens (2002) 1.00
Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. J Bone Miner Res (2011) 1.00
Bone density and hyperlipidemia: the T-lymphocyte connection. J Bone Miner Res (2010) 0.99
Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts. J Biol Chem (2007) 0.98
The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification. Circ Res (2011) 0.96
Hyperlipidemia impairs osteoanabolic effects of PTH. J Bone Miner Res (2008) 0.96
Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res (2002) 0.95
A dynamic model of calcific nodule destabilization in response to monocyte- and oxidized lipid-induced matrix metalloproteinases. Am J Physiol Cell Physiol (2011) 0.93
Thematic series on the pathobiology of vascular calcification: an introduction. Circ Res (2011) 0.93
Vascular calcification and its relation to bone calcification: possible underlying mechanisms. J Nucl Cardiol (2003) 0.92
Mechanical response of a calcified plaque model to fluid shear force. Ann Biomed Eng (2006) 0.92
Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem (2011) 0.92
Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol (2008) 0.92
T0901317, an LXR agonist, augments PKA-induced vascular cell calcification. FEBS Lett (2009) 0.90
PKA-induced receptor activator of NF-kappaB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification. J Biol Chem (2010) 0.88
The bone-vascular axis in chronic kidney disease. Curr Opin Nephrol Hypertens (2010) 0.87
Role of cellular cholesterol metabolism in vascular cell calcification. J Biol Chem (2011) 0.87
Nanoscale architecture in atherosclerotic calcification. Arterioscler Thromb Vasc Biol (2008) 0.86
Regulation of RANKL-induced osteoclastic differentiation by vascular cells. J Mol Cell Cardiol (2005) 0.86
Micro sensors: linking real-time oscillatory shear stress with vascular inflammatory responses. Ann Biomed Eng (2004) 0.86
Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids. J Lipid Res (2009) 0.83
Regulatory circuits controlling vascular cell calcification. Cell Mol Life Sci (2012) 0.83
Patterns of periodic holes created by increased cell motility. Interface Focus (2012) 0.82
Murine models of atherosclerotic calcification. Curr Drug Targets (2008) 0.82
Atmospheric ultrafine particles promote vascular calcification via the NF-κB signaling pathway. Am J Physiol Cell Physiol (2012) 0.81
Systems biology of vascular calcification. Trends Cardiovasc Med (2009) 0.80
Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice. Biochem Biophys Res Commun (2013) 0.80
Mechanisms linking osteoporosis with cardiovascular calcification. Curr Osteoporos Rep (2009) 0.79
Return to ectopia: stem cells in the artery wall. Arterioscler Thromb Vasc Biol (2005) 0.79
Skeleton key to vascular disease. J Am Coll Cardiol (2004) 0.78
The effects of hyperlipidemia on implant osseointegration in the mouse femur. J Oral Implantol (2013) 0.77
Directing tissue morphogenesis via self-assembly of vascular mesenchymal cells. Biomaterials (2012) 0.77
Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts. J Cell Biochem (2014) 0.76
Focal high cell density generates a gradient of patterns in self-organizing vascular mesenchymal cells. J Vasc Res (2012) 0.76
The hemosteoblast: friend or foe? Circ Res (2011) 0.76
Preferred mitotic orientation in pattern formation by vascular mesenchymal cells. Am J Physiol Heart Circ Physiol (2012) 0.76
Introduction to the Compendium on calcific aortic valve disease. Circ Res (2013) 0.75
Adipose rex: fat and fats that rule differentiation. Circ Res (2002) 0.75
Outcomes of a Novel Training Program for Physician-Scientists: Integrating Graduate Degree Training With Specialty Fellowship. J Grad Med Educ (2016) 0.75
A matter of degree: a commentary on "Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells". Free Radic Biol Med (2007) 0.75